Showing results (461-470 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 InhibitorYoung Shin Cho, Julian R Levell, Gang Liu, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E Williams, Sharadha Subramanian, Joelle Verhagen, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase InhibitorsJavier de Vicente, Parcharee Tivitmahaisoon, Pamela Berry, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in MiceIrawati K Kandela, Katherine J McAuliffe, Lauren E Cochran, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
An ATR-FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and AβJonas Schartner, Andreas Nabers, Brian Budde, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Identification of a Novel TRPM8 Agonist from Nutmeg: A Promising Cooling CompoundTomohiro Shirai, Kentaro Kumihashi, Mitsuyoshi Sakasai, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor TargetingSukhen C Ghosh, Servando Hernandez Vargas, Melissa Rodriguez, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor AntagonistsChad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Synthesis and Biological Evaluation of Paclitaxel and Camptothecin Prodrugs on the Basis of 2-NitroimidazoleChen Jin, Shuai Wen, Qiumeng Zhang, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Structure-Based Design and Synthesis of New Estrane-Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 InhibitorsRaphaël Dutour, Francisco Cortés-Benítez, Jenny Roy, et al.
Pageof 438